Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Continuous multi-factor scoring & catalyst forensics
Today's biggest gainers and losers
Glanbia is an Irish-based global nutrition company operating two primary divisions: Glanbia Performance Nutrition (sports nutrition brands including Optimum Nutrition, BSN, and Isopure) and Glanbia Nutritionals (whey protein ingredients and cheese production). The company derives approximately 75% of revenue from North America, with performance nutrition representing roughly 60% of total revenue and nutritionals/cheese the remainder. The stock trades on competitive positioning in the $18B global sports nutrition market and operational efficiency in dairy ingredient processing.
Glanbia generates margins through vertical integration from milk procurement to finished consumer products. The Performance Nutrition segment commands 25-30% gross margins through brand equity (Optimum Nutrition is the #1 sports nutrition brand globally by volume) and direct-to-consumer channels. The Nutritionals business operates on 15-20% gross margins, leveraging proprietary membrane filtration technology and long-term supply contracts with major food manufacturers. Pricing power varies: strong in branded nutrition (premium positioning), moderate in ingredients (commodity-plus pricing tied to milk and whey markets). The company benefits from scale advantages in whey processing with facilities in Idaho, Wisconsin, and New Mexico processing over 8 billion pounds of milk annually.
Optimum Nutrition brand volume growth and market share in US specialty retail (GNC, Vitamin Shoppe) and e-commerce (Amazon, direct-to-consumer)
Whey protein ingredient pricing and spreads over milk costs - typically tracked as whey protein concentrate 80% (WPC80) spot prices versus Class II milk
Gross margin trajectory in Performance Nutrition segment driven by promotional intensity, channel mix shift (DTC vs wholesale), and input costs
International expansion progress, particularly China sports nutrition market penetration and European ready-to-drink growth
Milk supply dynamics in US Upper Midwest affecting raw material costs and Nutritionals segment profitability
Retail channel disruption as GNC bankruptcy (2020) and specialty retailer consolidation reduce distribution points for Performance Nutrition, requiring accelerated DTC and mass market expansion
Regulatory scrutiny of sports nutrition claims and ingredient safety (particularly around novel ingredients and third-party testing requirements) could increase compliance costs and limit product innovation
Milk supply concentration risk with 70% of ingredient production in Idaho/Wisconsin facilities exposed to regional drought, water availability, and dairy farm consolidation trends
Private label and emerging DTC brands (Transparent Labs, Legion Athletics) gaining share in sports nutrition through lower pricing and social media marketing, pressuring Optimum Nutrition's premium positioning
Ingredient commoditization as whey protein becomes increasingly standardized with multiple global suppliers (Hilmar, Agropur, Fonterra) competing on price rather than differentiation
Vertical integration by large food companies (Nestlé, PepsiCo) into sports nutrition reducing third-party ingredient demand and increasing branded competition
Moderate leverage at 2.5x net debt/EBITDA (estimated) limits M&A flexibility and requires deleveraging focus if EBITDA declines further from current depressed levels
Pension obligations from Irish dairy cooperative legacy operations, though specific unfunded liability not disclosed in available data
Capital intensity of 3-4% of sales for maintenance capex on dairy processing equipment, with additional growth capex required for capacity expansion if demand recovers
moderate - Performance Nutrition exhibits defensive characteristics as fitness enthusiasts maintain supplement purchases through downturns, but premium product mix and new customer acquisition slow during recessions. The segment showed resilience during 2020 with at-home fitness trends offsetting gym closures. Nutritionals is more cyclical, tied to food manufacturing activity and infant formula demand (linked to birth rates and consumer confidence). Overall revenue correlation to GDP growth estimated at 0.6x, below typical consumer discretionary but above staples.
Rising rates have modest negative impact through two channels: (1) higher financing costs on $1.3B net debt (approximately 50% floating rate exposure based on typical corporate treasury management), adding 5-10bps to interest expense per 100bps rate increase, and (2) valuation multiple compression as investors rotate from growth-oriented consumer stocks to higher-yielding alternatives. Demand-side impact is minimal as sports nutrition purchases are not interest-rate sensitive. Current 0.51x debt/equity provides adequate cushion.
Minimal direct credit exposure. The business operates on short payment cycles with retail and distributor customers (30-60 day terms). Ingredient sales to food manufacturers involve established counterparties with strong credit profiles. Working capital requirements fluctuate with dairy commodity prices but are manageable given 1.67x current ratio and $400M operating cash flow generation.
value - The stock appeals to value investors given 1.2x P/S (below historical 1.5-2.0x range), 7.1% FCF yield, and potential for margin recovery as input costs normalize and operational restructuring gains traction. Recent 29% stock appreciation reflects recovery trade positioning. Limited appeal to growth investors given -29% revenue decline (likely reflecting divestitures or FX headwinds) and mature market positioning. Not a dividend story despite Consumer Defensive classification.
moderate - Historical beta estimated at 0.8-1.0 given consumer staples characteristics offset by commodity input exposure and international revenue mix. Stock exhibits 20-25% annualized volatility, elevated versus pure-play food companies due to sports nutrition category growth uncertainty and whey pricing swings. ADR structure (GLAPY) adds liquidity constraints and potential tracking error versus Irish primary listing.